Table of Content

Global Respiratory Drugs Market

1. Report Overview
1.1. Global Respiratory Drugs Market Overview
1.2. Why You Should Read This Report
1.3. How This Report Delivers
1.4. Key Questions Answered by This Analytical Report
1.5. Who is This Report For?
1.6. Methodology
1.6.1. Primary Research
1.6.2. Secondary Research
1.6.3. Market Evaluation & Forecasting Methodology

2. Introduction to the Respiratory Drugs Market
2.1. Respiratory Drugs Market Structure
2.2. Respiratory Drugs Market Definition
2.3. Global Respiratory Drugs Market Taxonomy
2.4. Global Respiratory Drugs Market Snapshot
2.5. Epidemiology Analysis
ASTHMA
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
CYSTIC FIBROSIS
PULMONARY HYPERTENSION
ALLERGIC RHINITIS
IDIOPATHIC PULMONARY FIBROSIS
2.6. Global Respiratory Drugs Market Dynamics
2.6.1. Global Respiratory Drugs Market: Driver
2.6.2. Global Respiratory Drugs Market: Restraints
2.6.1. Global Respiratory Drugs Market: Trends
2.6.1. Global Respiratory Drugs Market: Opportunities

3. Global Respiratory Drugs Market, By Drug Type, 2019-2027
3.1. Introduction
3.2. Global Respiratory Drugs Market Size and Forecast, By Drug Type
3.2.1. Anti-Asthmatics & COPD Drug Segment
3.2.2. Cough & Cold Preparations Drug Segment
3.2.3. Pulmonary Hypertension Segment
3.2.4. Idiopathic Pulmonary Fibrosis Segment

4. Global Respiratory Drugs Market, By Formulation, 2019-2027
4.1. Introduction
4.2. Global Respiratory Drugs Market Size and Forecast, By Formulation
4.2.1. Dry Powder Segment
4.2.2. Tablets & Capsules Segment
4.2.3. Sprays Segment
4.2.4. Syrups & Solutions Segment

5. Global Respiratory Drugs Market, By Disease, 2019-2027
5.1. Introduction
5.2. Global Respiratory Drugs Market Size and Forecast, By Disease
5.2.1. Asthma Segment
5.2.2. Chronic Obstructive Pulmonary Disease Segment
5.2.3. Cystic Fibrosis Segment
5.2.4. Pulmonary Hypertension Segment
5.2.5. Allergic Rhinitis Segment
5.2.6. Idiopathic Pulmonary Fibrosis Segment
5.2.7. Others Segment

6. Global Respiratory Drugs Market, By Administration, 2019-2027
6.1. Introduction
6.2. Global Respiratory Drugs Market Size and Forecast, By Administration
6.2.1. Stand Alone Drugs Segment
6.2.2. Combination Drugs Segment

7. Global Respiratory Drugs Market, By Drug Delivery, 2019-2027
7.1. Introduction
7.2. Global Respiratory Drugs Market Size and Forecast, By Drug Delivery
7.2.1. Inhalational Segment
7.2.2. Oral Segment
7.2.3. Injection Segment

8. Global Respiratory Drugs Market, By Distribution Channel, 2019-2027
8.1. Introduction
8.2. Global Respiratory Drugs Market Size and Forecast, By Distribution Channel
8.2.1. Online Segment
8.2.2. Offline Segment

9. Global Respiratory Drugs Market, By Region, 2019-2027
9.1. Introduction
9.2. Global Respiratory Drugs Market Size and Forecast, By Region
9.2.1. North America
9.2.2. Latin America
9.2.3. Europe
9.2.4. Asia Pacific
9.2.5. Middle East and Africa

10. North America Respiratory Drugs Market Analysis and Forecast, 2019-2027
10.1. Introduction
10.1.1. North America
10.2. North America Respiratory Drugs Market Forecast, By Country, 2019-2027
10.3. North America Respiratory Drugs Market Forecast, By Drug Type, 2019-2027
10.4. North America Respiratory Drugs Market Forecast, By Formulation, 2019-2027
10.5. North America Respiratory Drugs Market Forecast, By Disease, 2019-2027
10.6. North America Respiratory Drugs Market Forecast, By Administration, 2019-2027
10.7. North America Respiratory Drugs Market Forecast, By Drug Delivery, 2019-2027
10.8. North America Respiratory Drugs Market Forecast, By Distribution Channel, 2019-2027

11. Latin America Respiratory Drugs Market Analysis and Forecast, 2019-2027
11.1. Introduction
11.1.1. Latin America
11.2. Latin America Respiratory Drugs Market Forecast, By Country, 2019-2027
11.3. Latin America Respiratory Drugs Market Forecast, By Drug Type, 2019-2027
11.4. Latin America Respiratory Drugs Market Forecast, By Formulation, 2019-2027
11.5. Latin America Respiratory Drugs Market Forecast, By Disease, 2019-2027
11.6. Latin America Respiratory Drugs Market Forecast, By Administration, 2019-2027
11.7. Latin America Respiratory Drugs Market Forecast, By Drug Delivery, 2019-2027
11.8. Latin America Respiratory Drugs Market Forecast, By Distribution Channel, 2019-2027

12. Europe Respiratory Drugs Market Analysis and Forecast, 2019-2027
12.1. Introduction
12.1.1. Europe
12.2. Europe Respiratory Drugs Market Forecast, By Country, 2019-2027
12.3. Europe Respiratory Drugs Market Forecast, By Drug Type, 2019-2027
12.4. Europe Respiratory Drugs Market Forecast, By Formulation, 2019-2027
12.5. Europe Respiratory Drugs Market Forecast, By Disease, 2019-2027
12.6. Europe Respiratory Drugs Market Forecast, By Administration, 2019-2027
12.7. Europe Respiratory Drugs Market Forecast, By Drug Delivery, 2019-2027
12.8. Europe Respiratory Drugs Market Forecast, By Distribution Channel, 2019-2027

13. Asia Pacific Respiratory Drugs Market Analysis and Forecast, 2019-2027
13.1. Introduction
13.1.1. Asia Pacific
13.2. Asia Pacific Respiratory Drugs Market Forecast, By Country, 2019-2027
13.3. Asia Pacific Respiratory Drugs Market Forecast, By Drug Type, 2019-2027
13.4. Asia Pacific Respiratory Drugs Market Forecast, By Formulation, 2019-2027
13.5. Asia Pacific Respiratory Drugs Market Forecast, By Disease, 2019-2027
13.6. Asia Pacific Respiratory Drugs Market Forecast, By Administration, 2019-2027
13.7. Asia Pacific Respiratory Drugs Market Forecast, By Drug Delivery, 2019-2027
13.8. Asia Pacific Respiratory Drugs Market Forecast, By Distribution Channel, 2019-2027

14. Middle East & Africa Respiratory Drugs Market Analysis and Forecast, 2019-2027
14.1. Introduction
14.1.1. MEA
14.2. MEA Respiratory Drugs Market Forecast, By Country, 2019-2027
14.3. MEA Respiratory Drugs Market Forecast, By Drug Type, 2019-2027
14.4. MEA Respiratory Drugs Market Forecast, By Formulation, 2019-2027
14.5. MEA Respiratory Drugs Market Forecast, By Disease, 2019-2027
14.6. MEA Respiratory Drugs Market Forecast, By Administration, 2019-2027
14.7. MEA Respiratory Drugs Market Forecast, By Drug Delivery, 2019-2027
14.8. MEA Respiratory Drugs Market Forecast, By Distribution Channel, 2019-2027

15. Company Profile
15.1. ASTRAZENECA PLC
15.1.1. Overview
15.1.2. Product Type/Service Offerings
15.1.3. Key Developments
15.1.4. SWOT ANALYSIS
15.2. FIBROGEN, INC
15.2.1. Overview
15.2.2. Product Type/Service Offerings
15.2.3. SWOT Analysis
15.3. NOVARTIS INTERNATIONAL AG
15.3.1. Overview
15.3.2. Product Type/Service Offerings
15.3.3. Key Developments
15.3.4. SWOT ANALYSIS
15.4. ABBOTT LABORATORIES
15.4.1. Overview
15.4.2. Product Type/Service Offerings
15.4.3. SWOT Analysis
15.5. GLAXOSMITHKLINE PLC
15.5.1. Overview
15.5.2. Product Type/Service Offerings
15.5.3. SWOT Analysis
15.6. F. HOFFMANN-LA ROCHE AG
15.6.1. Overview
15.6.2. Product Type/Service Offerings
15.6.3. Key Developments
15.6.4. SWOT Analysis
15.7. MERCK & CO., INC
15.7.1. Overview
15.7.2. Product Type/Service Offerings
15.7.3. Strategy (s)
15.7.4. Key Developments
15.7.5. SWOT Analysis
15.8. SUNOVION PHARMACEUTICALS INC
15.8.1. Overview
15.8.2. Product Type/Service Offerings
15.8.3. SWOT Analysis
16. Respiratory Drugs Pipeline Analysis
16.1. ANTI-ASTHMATICS AND COPD DRUG
16.1.1. LONG-ACTING BETA-AGONISTS (LABA)
Study Description
Study Design
16.1.2. LONG-ACTING MUSCARINIC ANTAGONISTS (LAMA)
Study Description
Study Design
Study Description
Study Design
16.1.3. CORTICOSTEROIDS
Study Description
Study Design
Study Description
Study Design
Study Description
Study Design
16.1.4. LEUKOTRIENE
Study Description
Study Design
Study Description
Study Design
16.1.5. XANTHINES
Study Description
Study Design
16.2. COUGH AND COLD PREPARATIONS DRUG
16.2.1. ANTITUSSIVES
Study Description
Study Design
Study Description
Study Design
16.3. ANTIHISTAMINES
Study Description
Study Design
Study Description
Study Design
16.4. DECONGESTANTS
Study Description
Study Design
Study Description
Study Design
16.5. EXPECTORANTS
Study Description
Study Design
Study Description
Study Design
16.6. PULMONARY HYPERTENSION
16.6.1. ENDOTHELIN RECEPTOR ANTAGONISTS
Study Description
Study Design
16.6.2. ANTICOAGULANTS
Study Description
Study Design
Study Description
Study Design
16.7. DIURETICS
Study Description
Study Design
Study Description
Study Design
16.7.1. SOLUBLE GUANYLATE CYCLASE (SGC) STIMULATOR
Study Description
Study Design
Study Description
Study Design
16.8. IDIOPATHIC PULMONARY FIBROSIS
16.8.1. PIRFENIDONE
Study Description
Study Design
Study Description
Study Design
16.8.2. NINTEDANIB
Study Description
Study Design
Study Description
Study Design

17. Acronyms